Global Gefitinib Tablets Market Growth 2025-2031
The global Gefitinib Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Gefitinib Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Gefitinib Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Gefitinib Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Gefitinib Tablets players cover Qilu Pharmaceutical, Sichuan Kelun Pharmaceutical Co.,Ltd., Jiangsu Hengrui Pharmaceuticals Co.,ltd., Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd., Yangtze River Pharmaceutical (Group) Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Gefitinib Tablets Industry Forecast” looks at past sales and reviews total world Gefitinib Tablets sales in 2024, providing a comprehensive analysis by region and market sector of projected Gefitinib Tablets sales for 2025 through 2031. With Gefitinib Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gefitinib Tablets industry.
This Insight Report provides a comprehensive analysis of the global Gefitinib Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gefitinib Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gefitinib Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gefitinib Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gefitinib Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Gefitinib Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Gefitinib Tablets market?
What factors are driving Gefitinib Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Gefitinib Tablets market opportunities vary by end market size?
How does Gefitinib Tablets break out by Type, by Application?
United States market for Gefitinib Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Gefitinib Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Gefitinib Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Gefitinib Tablets players cover Qilu Pharmaceutical, Sichuan Kelun Pharmaceutical Co.,Ltd., Jiangsu Hengrui Pharmaceuticals Co.,ltd., Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd., Yangtze River Pharmaceutical (Group) Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Gefitinib Tablets Industry Forecast” looks at past sales and reviews total world Gefitinib Tablets sales in 2024, providing a comprehensive analysis by region and market sector of projected Gefitinib Tablets sales for 2025 through 2031. With Gefitinib Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gefitinib Tablets industry.
This Insight Report provides a comprehensive analysis of the global Gefitinib Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gefitinib Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gefitinib Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gefitinib Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gefitinib Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Gefitinib Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Original Drugs
- Generic Drugs
- Breast Cancer
- Lung Cancer
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Qilu Pharmaceutical
- Sichuan Kelun Pharmaceutical Co.,Ltd.
- Jiangsu Hengrui Pharmaceuticals Co.,ltd.
- Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd.
- Yangtze River Pharmaceutical (Group) Co., Ltd.
- Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.
- Shanghai DESANO Pharmaceuticals Holding Co., Ltd.
- NatcoPharma
- AstraZeneca plc
- Intelicure Lifesciences
- Weefsel Pharma
- Taj Pharmaceuticals
- Saintroy Lifescience
- Actiza Pharmaceutical
- Teva
What is the 10-year outlook for the global Gefitinib Tablets market?
What factors are driving Gefitinib Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Gefitinib Tablets market opportunities vary by end market size?
How does Gefitinib Tablets break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gefitinib Tablets Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Gefitinib Tablets by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Gefitinib Tablets by Country/Region, 2020, 2024 & 2031
2.2 Gefitinib Tablets Segment by Type
2.2.1 Original Drugs
2.2.2 Generic Drugs
2.3 Gefitinib Tablets Sales by Type
2.3.1 Global Gefitinib Tablets Sales Market Share by Type (2020-2025)
2.3.2 Global Gefitinib Tablets Revenue and Market Share by Type (2020-2025)
2.3.3 Global Gefitinib Tablets Sale Price by Type (2020-2025)
2.4 Gefitinib Tablets Segment by Application
2.4.1 Breast Cancer
2.4.2 Lung Cancer
2.4.3 Other
2.5 Gefitinib Tablets Sales by Application
2.5.1 Global Gefitinib Tablets Sale Market Share by Application (2020-2025)
2.5.2 Global Gefitinib Tablets Revenue and Market Share by Application (2020-2025)
2.5.3 Global Gefitinib Tablets Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Gefitinib Tablets Breakdown Data by Company
3.1.1 Global Gefitinib Tablets Annual Sales by Company (2020-2025)
3.1.2 Global Gefitinib Tablets Sales Market Share by Company (2020-2025)
3.2 Global Gefitinib Tablets Annual Revenue by Company (2020-2025)
3.2.1 Global Gefitinib Tablets Revenue by Company (2020-2025)
3.2.2 Global Gefitinib Tablets Revenue Market Share by Company (2020-2025)
3.3 Global Gefitinib Tablets Sale Price by Company
3.4 Key Manufacturers Gefitinib Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gefitinib Tablets Product Location Distribution
3.4.2 Players Gefitinib Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GEFITINIB TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Gefitinib Tablets Market Size by Geographic Region (2020-2025)
4.1.1 Global Gefitinib Tablets Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Gefitinib Tablets Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Gefitinib Tablets Market Size by Country/Region (2020-2025)
4.2.1 Global Gefitinib Tablets Annual Sales by Country/Region (2020-2025)
4.2.2 Global Gefitinib Tablets Annual Revenue by Country/Region (2020-2025)
4.3 Americas Gefitinib Tablets Sales Growth
4.4 APAC Gefitinib Tablets Sales Growth
4.5 Europe Gefitinib Tablets Sales Growth
4.6 Middle East & Africa Gefitinib Tablets Sales Growth
5 AMERICAS
5.1 Americas Gefitinib Tablets Sales by Country
5.1.1 Americas Gefitinib Tablets Sales by Country (2020-2025)
5.1.2 Americas Gefitinib Tablets Revenue by Country (2020-2025)
5.2 Americas Gefitinib Tablets Sales by Type (2020-2025)
5.3 Americas Gefitinib Tablets Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gefitinib Tablets Sales by Region
6.1.1 APAC Gefitinib Tablets Sales by Region (2020-2025)
6.1.2 APAC Gefitinib Tablets Revenue by Region (2020-2025)
6.2 APAC Gefitinib Tablets Sales by Type (2020-2025)
6.3 APAC Gefitinib Tablets Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Gefitinib Tablets by Country
7.1.1 Europe Gefitinib Tablets Sales by Country (2020-2025)
7.1.2 Europe Gefitinib Tablets Revenue by Country (2020-2025)
7.2 Europe Gefitinib Tablets Sales by Type (2020-2025)
7.3 Europe Gefitinib Tablets Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gefitinib Tablets by Country
8.1.1 Middle East & Africa Gefitinib Tablets Sales by Country (2020-2025)
8.1.2 Middle East & Africa Gefitinib Tablets Revenue by Country (2020-2025)
8.2 Middle East & Africa Gefitinib Tablets Sales by Type (2020-2025)
8.3 Middle East & Africa Gefitinib Tablets Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gefitinib Tablets
10.3 Manufacturing Process Analysis of Gefitinib Tablets
10.4 Industry Chain Structure of Gefitinib Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gefitinib Tablets Distributors
11.3 Gefitinib Tablets Customer
12 WORLD FORECAST REVIEW FOR GEFITINIB TABLETS BY GEOGRAPHIC REGION
12.1 Global Gefitinib Tablets Market Size Forecast by Region
12.1.1 Global Gefitinib Tablets Forecast by Region (2026-2031)
12.1.2 Global Gefitinib Tablets Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Gefitinib Tablets Forecast by Type (2026-2031)
12.7 Global Gefitinib Tablets Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Qilu Pharmaceutical
13.1.1 Qilu Pharmaceutical Company Information
13.1.2 Qilu Pharmaceutical Gefitinib Tablets Product Portfolios and Specifications
13.1.3 Qilu Pharmaceutical Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Qilu Pharmaceutical Main Business Overview
13.1.5 Qilu Pharmaceutical Latest Developments
13.2 Sichuan Kelun Pharmaceutical Co.,Ltd.
13.2.1 Sichuan Kelun Pharmaceutical Co.,Ltd. Company Information
13.2.2 Sichuan Kelun Pharmaceutical Co.,Ltd. Gefitinib Tablets Product Portfolios and Specifications
13.2.3 Sichuan Kelun Pharmaceutical Co.,Ltd. Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Sichuan Kelun Pharmaceutical Co.,Ltd. Main Business Overview
13.2.5 Sichuan Kelun Pharmaceutical Co.,Ltd. Latest Developments
13.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd.
13.3.1 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Company Information
13.3.2 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Gefitinib Tablets Product Portfolios and Specifications
13.3.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Main Business Overview
13.3.5 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Latest Developments
13.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd.
13.4.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Company Information
13.4.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Gefitinib Tablets Product Portfolios and Specifications
13.4.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Main Business Overview
13.4.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Latest Developments
13.5 Yangtze River Pharmaceutical (Group) Co., Ltd.
13.5.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
13.5.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Gefitinib Tablets Product Portfolios and Specifications
13.5.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Main Business Overview
13.5.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Latest Developments
13.6 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.
13.6.1 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Company Information
13.6.2 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Gefitinib Tablets Product Portfolios and Specifications
13.6.3 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Main Business Overview
13.6.5 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Latest Developments
13.7 Shanghai DESANO Pharmaceuticals Holding Co., Ltd.
13.7.1 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Company Information
13.7.2 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Gefitinib Tablets Product Portfolios and Specifications
13.7.3 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Main Business Overview
13.7.5 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Latest Developments
13.8 NatcoPharma
13.8.1 NatcoPharma Company Information
13.8.2 NatcoPharma Gefitinib Tablets Product Portfolios and Specifications
13.8.3 NatcoPharma Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 NatcoPharma Main Business Overview
13.8.5 NatcoPharma Latest Developments
13.9 AstraZeneca plc
13.9.1 AstraZeneca plc Company Information
13.9.2 AstraZeneca plc Gefitinib Tablets Product Portfolios and Specifications
13.9.3 AstraZeneca plc Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 AstraZeneca plc Main Business Overview
13.9.5 AstraZeneca plc Latest Developments
13.10 Intelicure Lifesciences
13.10.1 Intelicure Lifesciences Company Information
13.10.2 Intelicure Lifesciences Gefitinib Tablets Product Portfolios and Specifications
13.10.3 Intelicure Lifesciences Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Intelicure Lifesciences Main Business Overview
13.10.5 Intelicure Lifesciences Latest Developments
13.11 Weefsel Pharma
13.11.1 Weefsel Pharma Company Information
13.11.2 Weefsel Pharma Gefitinib Tablets Product Portfolios and Specifications
13.11.3 Weefsel Pharma Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Weefsel Pharma Main Business Overview
13.11.5 Weefsel Pharma Latest Developments
13.12 Taj Pharmaceuticals
13.12.1 Taj Pharmaceuticals Company Information
13.12.2 Taj Pharmaceuticals Gefitinib Tablets Product Portfolios and Specifications
13.12.3 Taj Pharmaceuticals Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Taj Pharmaceuticals Main Business Overview
13.12.5 Taj Pharmaceuticals Latest Developments
13.13 Saintroy Lifescience
13.13.1 Saintroy Lifescience Company Information
13.13.2 Saintroy Lifescience Gefitinib Tablets Product Portfolios and Specifications
13.13.3 Saintroy Lifescience Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Saintroy Lifescience Main Business Overview
13.13.5 Saintroy Lifescience Latest Developments
13.14 Actiza Pharmaceutical
13.14.1 Actiza Pharmaceutical Company Information
13.14.2 Actiza Pharmaceutical Gefitinib Tablets Product Portfolios and Specifications
13.14.3 Actiza Pharmaceutical Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Actiza Pharmaceutical Main Business Overview
13.14.5 Actiza Pharmaceutical Latest Developments
13.15 Teva
13.15.1 Teva Company Information
13.15.2 Teva Gefitinib Tablets Product Portfolios and Specifications
13.15.3 Teva Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Teva Main Business Overview
13.15.5 Teva Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gefitinib Tablets Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Gefitinib Tablets by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Gefitinib Tablets by Country/Region, 2020, 2024 & 2031
2.2 Gefitinib Tablets Segment by Type
2.2.1 Original Drugs
2.2.2 Generic Drugs
2.3 Gefitinib Tablets Sales by Type
2.3.1 Global Gefitinib Tablets Sales Market Share by Type (2020-2025)
2.3.2 Global Gefitinib Tablets Revenue and Market Share by Type (2020-2025)
2.3.3 Global Gefitinib Tablets Sale Price by Type (2020-2025)
2.4 Gefitinib Tablets Segment by Application
2.4.1 Breast Cancer
2.4.2 Lung Cancer
2.4.3 Other
2.5 Gefitinib Tablets Sales by Application
2.5.1 Global Gefitinib Tablets Sale Market Share by Application (2020-2025)
2.5.2 Global Gefitinib Tablets Revenue and Market Share by Application (2020-2025)
2.5.3 Global Gefitinib Tablets Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Gefitinib Tablets Breakdown Data by Company
3.1.1 Global Gefitinib Tablets Annual Sales by Company (2020-2025)
3.1.2 Global Gefitinib Tablets Sales Market Share by Company (2020-2025)
3.2 Global Gefitinib Tablets Annual Revenue by Company (2020-2025)
3.2.1 Global Gefitinib Tablets Revenue by Company (2020-2025)
3.2.2 Global Gefitinib Tablets Revenue Market Share by Company (2020-2025)
3.3 Global Gefitinib Tablets Sale Price by Company
3.4 Key Manufacturers Gefitinib Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gefitinib Tablets Product Location Distribution
3.4.2 Players Gefitinib Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GEFITINIB TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Gefitinib Tablets Market Size by Geographic Region (2020-2025)
4.1.1 Global Gefitinib Tablets Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Gefitinib Tablets Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Gefitinib Tablets Market Size by Country/Region (2020-2025)
4.2.1 Global Gefitinib Tablets Annual Sales by Country/Region (2020-2025)
4.2.2 Global Gefitinib Tablets Annual Revenue by Country/Region (2020-2025)
4.3 Americas Gefitinib Tablets Sales Growth
4.4 APAC Gefitinib Tablets Sales Growth
4.5 Europe Gefitinib Tablets Sales Growth
4.6 Middle East & Africa Gefitinib Tablets Sales Growth
5 AMERICAS
5.1 Americas Gefitinib Tablets Sales by Country
5.1.1 Americas Gefitinib Tablets Sales by Country (2020-2025)
5.1.2 Americas Gefitinib Tablets Revenue by Country (2020-2025)
5.2 Americas Gefitinib Tablets Sales by Type (2020-2025)
5.3 Americas Gefitinib Tablets Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gefitinib Tablets Sales by Region
6.1.1 APAC Gefitinib Tablets Sales by Region (2020-2025)
6.1.2 APAC Gefitinib Tablets Revenue by Region (2020-2025)
6.2 APAC Gefitinib Tablets Sales by Type (2020-2025)
6.3 APAC Gefitinib Tablets Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Gefitinib Tablets by Country
7.1.1 Europe Gefitinib Tablets Sales by Country (2020-2025)
7.1.2 Europe Gefitinib Tablets Revenue by Country (2020-2025)
7.2 Europe Gefitinib Tablets Sales by Type (2020-2025)
7.3 Europe Gefitinib Tablets Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gefitinib Tablets by Country
8.1.1 Middle East & Africa Gefitinib Tablets Sales by Country (2020-2025)
8.1.2 Middle East & Africa Gefitinib Tablets Revenue by Country (2020-2025)
8.2 Middle East & Africa Gefitinib Tablets Sales by Type (2020-2025)
8.3 Middle East & Africa Gefitinib Tablets Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gefitinib Tablets
10.3 Manufacturing Process Analysis of Gefitinib Tablets
10.4 Industry Chain Structure of Gefitinib Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gefitinib Tablets Distributors
11.3 Gefitinib Tablets Customer
12 WORLD FORECAST REVIEW FOR GEFITINIB TABLETS BY GEOGRAPHIC REGION
12.1 Global Gefitinib Tablets Market Size Forecast by Region
12.1.1 Global Gefitinib Tablets Forecast by Region (2026-2031)
12.1.2 Global Gefitinib Tablets Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Gefitinib Tablets Forecast by Type (2026-2031)
12.7 Global Gefitinib Tablets Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Qilu Pharmaceutical
13.1.1 Qilu Pharmaceutical Company Information
13.1.2 Qilu Pharmaceutical Gefitinib Tablets Product Portfolios and Specifications
13.1.3 Qilu Pharmaceutical Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Qilu Pharmaceutical Main Business Overview
13.1.5 Qilu Pharmaceutical Latest Developments
13.2 Sichuan Kelun Pharmaceutical Co.,Ltd.
13.2.1 Sichuan Kelun Pharmaceutical Co.,Ltd. Company Information
13.2.2 Sichuan Kelun Pharmaceutical Co.,Ltd. Gefitinib Tablets Product Portfolios and Specifications
13.2.3 Sichuan Kelun Pharmaceutical Co.,Ltd. Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Sichuan Kelun Pharmaceutical Co.,Ltd. Main Business Overview
13.2.5 Sichuan Kelun Pharmaceutical Co.,Ltd. Latest Developments
13.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd.
13.3.1 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Company Information
13.3.2 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Gefitinib Tablets Product Portfolios and Specifications
13.3.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Main Business Overview
13.3.5 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Latest Developments
13.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd.
13.4.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Company Information
13.4.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Gefitinib Tablets Product Portfolios and Specifications
13.4.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Main Business Overview
13.4.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Latest Developments
13.5 Yangtze River Pharmaceutical (Group) Co., Ltd.
13.5.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
13.5.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Gefitinib Tablets Product Portfolios and Specifications
13.5.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Main Business Overview
13.5.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Latest Developments
13.6 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.
13.6.1 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Company Information
13.6.2 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Gefitinib Tablets Product Portfolios and Specifications
13.6.3 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Main Business Overview
13.6.5 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Latest Developments
13.7 Shanghai DESANO Pharmaceuticals Holding Co., Ltd.
13.7.1 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Company Information
13.7.2 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Gefitinib Tablets Product Portfolios and Specifications
13.7.3 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Main Business Overview
13.7.5 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Latest Developments
13.8 NatcoPharma
13.8.1 NatcoPharma Company Information
13.8.2 NatcoPharma Gefitinib Tablets Product Portfolios and Specifications
13.8.3 NatcoPharma Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 NatcoPharma Main Business Overview
13.8.5 NatcoPharma Latest Developments
13.9 AstraZeneca plc
13.9.1 AstraZeneca plc Company Information
13.9.2 AstraZeneca plc Gefitinib Tablets Product Portfolios and Specifications
13.9.3 AstraZeneca plc Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 AstraZeneca plc Main Business Overview
13.9.5 AstraZeneca plc Latest Developments
13.10 Intelicure Lifesciences
13.10.1 Intelicure Lifesciences Company Information
13.10.2 Intelicure Lifesciences Gefitinib Tablets Product Portfolios and Specifications
13.10.3 Intelicure Lifesciences Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Intelicure Lifesciences Main Business Overview
13.10.5 Intelicure Lifesciences Latest Developments
13.11 Weefsel Pharma
13.11.1 Weefsel Pharma Company Information
13.11.2 Weefsel Pharma Gefitinib Tablets Product Portfolios and Specifications
13.11.3 Weefsel Pharma Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Weefsel Pharma Main Business Overview
13.11.5 Weefsel Pharma Latest Developments
13.12 Taj Pharmaceuticals
13.12.1 Taj Pharmaceuticals Company Information
13.12.2 Taj Pharmaceuticals Gefitinib Tablets Product Portfolios and Specifications
13.12.3 Taj Pharmaceuticals Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Taj Pharmaceuticals Main Business Overview
13.12.5 Taj Pharmaceuticals Latest Developments
13.13 Saintroy Lifescience
13.13.1 Saintroy Lifescience Company Information
13.13.2 Saintroy Lifescience Gefitinib Tablets Product Portfolios and Specifications
13.13.3 Saintroy Lifescience Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Saintroy Lifescience Main Business Overview
13.13.5 Saintroy Lifescience Latest Developments
13.14 Actiza Pharmaceutical
13.14.1 Actiza Pharmaceutical Company Information
13.14.2 Actiza Pharmaceutical Gefitinib Tablets Product Portfolios and Specifications
13.14.3 Actiza Pharmaceutical Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Actiza Pharmaceutical Main Business Overview
13.14.5 Actiza Pharmaceutical Latest Developments
13.15 Teva
13.15.1 Teva Company Information
13.15.2 Teva Gefitinib Tablets Product Portfolios and Specifications
13.15.3 Teva Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Teva Main Business Overview
13.15.5 Teva Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. GefitinibTablets Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. GefitinibTablets Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Original Drugs
Table 4. Major Players of Generic Drugs
Table 5. Global GefitinibTablets Sales by Type (2020-2025) & (K Units)
Table 6. Global GefitinibTablets Sales Market Share by Type (2020-2025)
Table 7. Global GefitinibTablets Revenue by Type (2020-2025) & ($ million)
Table 8. Global GefitinibTablets Revenue Market Share by Type (2020-2025)
Table 9. Global GefitinibTablets Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global GefitinibTablets Sale by Application (2020-2025) & (K Units)
Table 11. Global GefitinibTablets Sale Market Share by Application (2020-2025)
Table 12. Global GefitinibTablets Revenue by Application (2020-2025) & ($ million)
Table 13. Global GefitinibTablets Revenue Market Share by Application (2020-2025)
Table 14. Global GefitinibTablets Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global GefitinibTablets Sales by Company (2020-2025) & (K Units)
Table 16. Global GefitinibTablets Sales Market Share by Company (2020-2025)
Table 17. Global GefitinibTablets Revenue by Company (2020-2025) & ($ millions)
Table 18. Global GefitinibTablets Revenue Market Share by Company (2020-2025)
Table 19. Global GefitinibTablets Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers GefitinibTablets Producing Area Distribution and Sales Area
Table 21. Players GefitinibTablets Products Offered
Table 22. GefitinibTablets Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global GefitinibTablets Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global GefitinibTablets Sales Market Share Geographic Region (2020-2025)
Table 27. Global GefitinibTablets Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global GefitinibTablets Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global GefitinibTablets Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global GefitinibTablets Sales Market Share by Country/Region (2020-2025)
Table 31. Global GefitinibTablets Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global GefitinibTablets Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas GefitinibTablets Sales by Country (2020-2025) & (K Units)
Table 34. Americas GefitinibTablets Sales Market Share by Country (2020-2025)
Table 35. Americas GefitinibTablets Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas GefitinibTablets Sales by Type (2020-2025) & (K Units)
Table 37. Americas GefitinibTablets Sales by Application (2020-2025) & (K Units)
Table 38. APAC GefitinibTablets Sales by Region (2020-2025) & (K Units)
Table 39. APAC GefitinibTablets Sales Market Share by Region (2020-2025)
Table 40. APAC GefitinibTablets Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC GefitinibTablets Sales by Type (2020-2025) & (K Units)
Table 42. APAC GefitinibTablets Sales by Application (2020-2025) & (K Units)
Table 43. Europe GefitinibTablets Sales by Country (2020-2025) & (K Units)
Table 44. Europe GefitinibTablets Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe GefitinibTablets Sales by Type (2020-2025) & (K Units)
Table 46. Europe GefitinibTablets Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa GefitinibTablets Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa GefitinibTablets Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa GefitinibTablets Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa GefitinibTablets Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of GefitinibTablets
Table 52. Key Market Challenges & Risks of GefitinibTablets
Table 53. Key Industry Trends of GefitinibTablets
Table 54. GefitinibTablets Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. GefitinibTablets Distributors List
Table 57. GefitinibTablets Customer List
Table 58. Global GefitinibTablets Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global GefitinibTablets Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas GefitinibTablets Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas GefitinibTablets Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC GefitinibTablets Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC GefitinibTablets Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe GefitinibTablets Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe GefitinibTablets Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa GefitinibTablets Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa GefitinibTablets Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global GefitinibTablets Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global GefitinibTablets Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global GefitinibTablets Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global GefitinibTablets Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Qilu Pharmaceutical Basic Information, GefitinibTablets Manufacturing Base, Sales Area and Its Competitors
Table 73. Qilu Pharmaceutical GefitinibTablets Product Portfolios and Specifications
Table 74. Qilu Pharmaceutical GefitinibTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Qilu Pharmaceutical Main Business
Table 76. Qilu Pharmaceutical Latest Developments
Table 77. Sichuan Kelun Pharmaceutical Co.,Ltd. Basic Information, GefitinibTablets Manufacturing Base, Sales Area and Its Competitors
Table 78. Sichuan Kelun Pharmaceutical Co.,Ltd. GefitinibTablets Product Portfolios and Specifications
Table 79. Sichuan Kelun Pharmaceutical Co.,Ltd. GefitinibTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Sichuan Kelun Pharmaceutical Co.,Ltd. Main Business
Table 81. Sichuan Kelun Pharmaceutical Co.,Ltd. Latest Developments
Table 82. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Basic Information, GefitinibTablets Manufacturing Base, Sales Area and Its Competitors
Table 83. Jiangsu Hengrui Pharmaceuticals Co.,ltd. GefitinibTablets Product Portfolios and Specifications
Table 84. Jiangsu Hengrui Pharmaceuticals Co.,ltd. GefitinibTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Main Business
Table 86. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Latest Developments
Table 87. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Basic Information, GefitinibTablets Manufacturing Base, Sales Area and Its Competitors
Table 88. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. GefitinibTablets Product Portfolios and Specifications
Table 89. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. GefitinibTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Main Business
Table 91. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Latest Developments
Table 92. Yangtze River Pharmaceutical (Group) Co., Ltd. Basic Information, GefitinibTablets Manufacturing Base, Sales Area and Its Competitors
Table 93. Yangtze River Pharmaceutical (Group) Co., Ltd. GefitinibTablets Product Portfolios and Specifications
Table 94. Yangtze River Pharmaceutical (Group) Co., Ltd. GefitinibTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Yangtze River Pharmaceutical (Group) Co., Ltd. Main Business
Table 96. Yangtze River Pharmaceutical (Group) Co., Ltd. Latest Developments
Table 97. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Basic Information, GefitinibTablets Manufacturing Base, Sales Area and Its Competitors
Table 98. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. GefitinibTablets Product Portfolios and Specifications
Table 99. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. GefitinibTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Main Business
Table 101. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Latest Developments
Table 102. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Basic Information, GefitinibTablets Manufacturing Base, Sales Area and Its Competitors
Table 103. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. GefitinibTablets Product Portfolios and Specifications
Table 104. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. GefitinibTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Main Business
Table 106. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Latest Developments
Table 107. NatcoPharma Basic Information, GefitinibTablets Manufacturing Base, Sales Area and Its Competitors
Table 108. NatcoPharma GefitinibTablets Product Portfolios and Specifications
Table 109. NatcoPharma GefitinibTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. NatcoPharma Main Business
Table 111. NatcoPharma Latest Developments
Table 112. AstraZeneca plc Basic Information, GefitinibTablets Manufacturing Base, Sales Area and Its Competitors
Table 113. AstraZeneca plc GefitinibTablets Product Portfolios and Specifications
Table 114. AstraZeneca plc GefitinibTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. AstraZeneca plc Main Business
Table 116. AstraZeneca plc Latest Developments
Table 117. Intelicure Lifesciences Basic Information, GefitinibTablets Manufacturing Base, Sales Area and Its Competitors
Table 118. Intelicure Lifesciences GefitinibTablets Product Portfolios and Specifications
Table 119. Intelicure Lifesciences GefitinibTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Intelicure Lifesciences Main Business
Table 121. Intelicure Lifesciences Latest Developments
Table 122. Weefsel Pharma Basic Information, GefitinibTablets Manufacturing Base, Sales Area and Its Competitors
Table 123. Weefsel Pharma GefitinibTablets Product Portfolios and Specifications
Table 124. Weefsel Pharma GefitinibTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. Weefsel Pharma Main Business
Table 126. Weefsel Pharma Latest Developments
Table 127. Taj Pharmaceuticals Basic Information, GefitinibTablets Manufacturing Base, Sales Area and Its Competitors
Table 128. Taj Pharmaceuticals GefitinibTablets Product Portfolios and Specifications
Table 129. Taj Pharmaceuticals GefitinibTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 130. Taj Pharmaceuticals Main Business
Table 131. Taj Pharmaceuticals Latest Developments
Table 132. Saintroy Lifescience Basic Information, GefitinibTablets Manufacturing Base, Sales Area and Its Competitors
Table 133. Saintroy Lifescience GefitinibTablets Product Portfolios and Specifications
Table 134. Saintroy Lifescience GefitinibTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 135. Saintroy Lifescience Main Business
Table 136. Saintroy Lifescience Latest Developments
Table 137. Actiza Pharmaceutical Basic Information, GefitinibTablets Manufacturing Base, Sales Area and Its Competitors
Table 138. Actiza Pharmaceutical GefitinibTablets Product Portfolios and Specifications
Table 139. Actiza Pharmaceutical GefitinibTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 140. Actiza Pharmaceutical Main Business
Table 141. Actiza Pharmaceutical Latest Developments
Table 142. Teva Basic Information, GefitinibTablets Manufacturing Base, Sales Area and Its Competitors
Table 143. Teva GefitinibTablets Product Portfolios and Specifications
Table 144. Teva GefitinibTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 145. Teva Main Business
Table 146. Teva Latest Developments
Table 1. GefitinibTablets Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. GefitinibTablets Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Original Drugs
Table 4. Major Players of Generic Drugs
Table 5. Global GefitinibTablets Sales by Type (2020-2025) & (K Units)
Table 6. Global GefitinibTablets Sales Market Share by Type (2020-2025)
Table 7. Global GefitinibTablets Revenue by Type (2020-2025) & ($ million)
Table 8. Global GefitinibTablets Revenue Market Share by Type (2020-2025)
Table 9. Global GefitinibTablets Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global GefitinibTablets Sale by Application (2020-2025) & (K Units)
Table 11. Global GefitinibTablets Sale Market Share by Application (2020-2025)
Table 12. Global GefitinibTablets Revenue by Application (2020-2025) & ($ million)
Table 13. Global GefitinibTablets Revenue Market Share by Application (2020-2025)
Table 14. Global GefitinibTablets Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global GefitinibTablets Sales by Company (2020-2025) & (K Units)
Table 16. Global GefitinibTablets Sales Market Share by Company (2020-2025)
Table 17. Global GefitinibTablets Revenue by Company (2020-2025) & ($ millions)
Table 18. Global GefitinibTablets Revenue Market Share by Company (2020-2025)
Table 19. Global GefitinibTablets Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers GefitinibTablets Producing Area Distribution and Sales Area
Table 21. Players GefitinibTablets Products Offered
Table 22. GefitinibTablets Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global GefitinibTablets Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global GefitinibTablets Sales Market Share Geographic Region (2020-2025)
Table 27. Global GefitinibTablets Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global GefitinibTablets Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global GefitinibTablets Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global GefitinibTablets Sales Market Share by Country/Region (2020-2025)
Table 31. Global GefitinibTablets Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global GefitinibTablets Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas GefitinibTablets Sales by Country (2020-2025) & (K Units)
Table 34. Americas GefitinibTablets Sales Market Share by Country (2020-2025)
Table 35. Americas GefitinibTablets Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas GefitinibTablets Sales by Type (2020-2025) & (K Units)
Table 37. Americas GefitinibTablets Sales by Application (2020-2025) & (K Units)
Table 38. APAC GefitinibTablets Sales by Region (2020-2025) & (K Units)
Table 39. APAC GefitinibTablets Sales Market Share by Region (2020-2025)
Table 40. APAC GefitinibTablets Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC GefitinibTablets Sales by Type (2020-2025) & (K Units)
Table 42. APAC GefitinibTablets Sales by Application (2020-2025) & (K Units)
Table 43. Europe GefitinibTablets Sales by Country (2020-2025) & (K Units)
Table 44. Europe GefitinibTablets Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe GefitinibTablets Sales by Type (2020-2025) & (K Units)
Table 46. Europe GefitinibTablets Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa GefitinibTablets Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa GefitinibTablets Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa GefitinibTablets Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa GefitinibTablets Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of GefitinibTablets
Table 52. Key Market Challenges & Risks of GefitinibTablets
Table 53. Key Industry Trends of GefitinibTablets
Table 54. GefitinibTablets Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. GefitinibTablets Distributors List
Table 57. GefitinibTablets Customer List
Table 58. Global GefitinibTablets Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global GefitinibTablets Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas GefitinibTablets Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas GefitinibTablets Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC GefitinibTablets Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC GefitinibTablets Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe GefitinibTablets Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe GefitinibTablets Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa GefitinibTablets Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa GefitinibTablets Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global GefitinibTablets Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global GefitinibTablets Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global GefitinibTablets Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global GefitinibTablets Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Qilu Pharmaceutical Basic Information, GefitinibTablets Manufacturing Base, Sales Area and Its Competitors
Table 73. Qilu Pharmaceutical GefitinibTablets Product Portfolios and Specifications
Table 74. Qilu Pharmaceutical GefitinibTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Qilu Pharmaceutical Main Business
Table 76. Qilu Pharmaceutical Latest Developments
Table 77. Sichuan Kelun Pharmaceutical Co.,Ltd. Basic Information, GefitinibTablets Manufacturing Base, Sales Area and Its Competitors
Table 78. Sichuan Kelun Pharmaceutical Co.,Ltd. GefitinibTablets Product Portfolios and Specifications
Table 79. Sichuan Kelun Pharmaceutical Co.,Ltd. GefitinibTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Sichuan Kelun Pharmaceutical Co.,Ltd. Main Business
Table 81. Sichuan Kelun Pharmaceutical Co.,Ltd. Latest Developments
Table 82. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Basic Information, GefitinibTablets Manufacturing Base, Sales Area and Its Competitors
Table 83. Jiangsu Hengrui Pharmaceuticals Co.,ltd. GefitinibTablets Product Portfolios and Specifications
Table 84. Jiangsu Hengrui Pharmaceuticals Co.,ltd. GefitinibTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Main Business
Table 86. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Latest Developments
Table 87. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Basic Information, GefitinibTablets Manufacturing Base, Sales Area and Its Competitors
Table 88. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. GefitinibTablets Product Portfolios and Specifications
Table 89. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. GefitinibTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Main Business
Table 91. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Latest Developments
Table 92. Yangtze River Pharmaceutical (Group) Co., Ltd. Basic Information, GefitinibTablets Manufacturing Base, Sales Area and Its Competitors
Table 93. Yangtze River Pharmaceutical (Group) Co., Ltd. GefitinibTablets Product Portfolios and Specifications
Table 94. Yangtze River Pharmaceutical (Group) Co., Ltd. GefitinibTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Yangtze River Pharmaceutical (Group) Co., Ltd. Main Business
Table 96. Yangtze River Pharmaceutical (Group) Co., Ltd. Latest Developments
Table 97. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Basic Information, GefitinibTablets Manufacturing Base, Sales Area and Its Competitors
Table 98. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. GefitinibTablets Product Portfolios and Specifications
Table 99. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. GefitinibTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Main Business
Table 101. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Latest Developments
Table 102. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Basic Information, GefitinibTablets Manufacturing Base, Sales Area and Its Competitors
Table 103. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. GefitinibTablets Product Portfolios and Specifications
Table 104. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. GefitinibTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Main Business
Table 106. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Latest Developments
Table 107. NatcoPharma Basic Information, GefitinibTablets Manufacturing Base, Sales Area and Its Competitors
Table 108. NatcoPharma GefitinibTablets Product Portfolios and Specifications
Table 109. NatcoPharma GefitinibTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. NatcoPharma Main Business
Table 111. NatcoPharma Latest Developments
Table 112. AstraZeneca plc Basic Information, GefitinibTablets Manufacturing Base, Sales Area and Its Competitors
Table 113. AstraZeneca plc GefitinibTablets Product Portfolios and Specifications
Table 114. AstraZeneca plc GefitinibTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. AstraZeneca plc Main Business
Table 116. AstraZeneca plc Latest Developments
Table 117. Intelicure Lifesciences Basic Information, GefitinibTablets Manufacturing Base, Sales Area and Its Competitors
Table 118. Intelicure Lifesciences GefitinibTablets Product Portfolios and Specifications
Table 119. Intelicure Lifesciences GefitinibTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Intelicure Lifesciences Main Business
Table 121. Intelicure Lifesciences Latest Developments
Table 122. Weefsel Pharma Basic Information, GefitinibTablets Manufacturing Base, Sales Area and Its Competitors
Table 123. Weefsel Pharma GefitinibTablets Product Portfolios and Specifications
Table 124. Weefsel Pharma GefitinibTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. Weefsel Pharma Main Business
Table 126. Weefsel Pharma Latest Developments
Table 127. Taj Pharmaceuticals Basic Information, GefitinibTablets Manufacturing Base, Sales Area and Its Competitors
Table 128. Taj Pharmaceuticals GefitinibTablets Product Portfolios and Specifications
Table 129. Taj Pharmaceuticals GefitinibTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 130. Taj Pharmaceuticals Main Business
Table 131. Taj Pharmaceuticals Latest Developments
Table 132. Saintroy Lifescience Basic Information, GefitinibTablets Manufacturing Base, Sales Area and Its Competitors
Table 133. Saintroy Lifescience GefitinibTablets Product Portfolios and Specifications
Table 134. Saintroy Lifescience GefitinibTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 135. Saintroy Lifescience Main Business
Table 136. Saintroy Lifescience Latest Developments
Table 137. Actiza Pharmaceutical Basic Information, GefitinibTablets Manufacturing Base, Sales Area and Its Competitors
Table 138. Actiza Pharmaceutical GefitinibTablets Product Portfolios and Specifications
Table 139. Actiza Pharmaceutical GefitinibTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 140. Actiza Pharmaceutical Main Business
Table 141. Actiza Pharmaceutical Latest Developments
Table 142. Teva Basic Information, GefitinibTablets Manufacturing Base, Sales Area and Its Competitors
Table 143. Teva GefitinibTablets Product Portfolios and Specifications
Table 144. Teva GefitinibTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 145. Teva Main Business
Table 146. Teva Latest Developments
LIST OF FIGURES
Figure 1. Picture of GefitinibTablets
Figure 2. GefitinibTablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global GefitinibTablets Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global GefitinibTablets Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. GefitinibTablets Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. GefitinibTablets Sales Market Share by Country/Region (2024)
Figure 10. GefitinibTablets Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Original Drugs
Figure 12. Product Picture of Generic Drugs
Figure 13. Global GefitinibTablets Sales Market Share by Type in 2025
Figure 14. Global GefitinibTablets Revenue Market Share by Type (2020-2025)
Figure 15. GefitinibTablets Consumed in Breast Cancer
Figure 16. Global GefitinibTablets Market: Breast Cancer (2020-2025) & (K Units)
Figure 17. GefitinibTablets Consumed in Lung Cancer
Figure 18. Global GefitinibTablets Market: Lung Cancer (2020-2025) & (K Units)
Figure 19. GefitinibTablets Consumed in Other
Figure 20. Global GefitinibTablets Market: Other (2020-2025) & (K Units)
Figure 21. Global GefitinibTablets Sale Market Share by Application (2024)
Figure 22. Global GefitinibTablets Revenue Market Share by Application in 2025
Figure 23. GefitinibTablets Sales by Company in 2025 (K Units)
Figure 24. Global GefitinibTablets Sales Market Share by Company in 2025
Figure 25. GefitinibTablets Revenue by Company in 2025 ($ millions)
Figure 26. Global GefitinibTablets Revenue Market Share by Company in 2025
Figure 27. Global GefitinibTablets Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global GefitinibTablets Revenue Market Share by Geographic Region in 2025
Figure 29. Americas GefitinibTablets Sales 2020-2025 (K Units)
Figure 30. Americas GefitinibTablets Revenue 2020-2025 ($ millions)
Figure 31. APAC GefitinibTablets Sales 2020-2025 (K Units)
Figure 32. APAC GefitinibTablets Revenue 2020-2025 ($ millions)
Figure 33. Europe GefitinibTablets Sales 2020-2025 (K Units)
Figure 34. Europe GefitinibTablets Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa GefitinibTablets Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa GefitinibTablets Revenue 2020-2025 ($ millions)
Figure 37. Americas GefitinibTablets Sales Market Share by Country in 2025
Figure 38. Americas GefitinibTablets Revenue Market Share by Country (2020-2025)
Figure 39. Americas GefitinibTablets Sales Market Share by Type (2020-2025)
Figure 40. Americas GefitinibTablets Sales Market Share by Application (2020-2025)
Figure 41. United States GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC GefitinibTablets Sales Market Share by Region in 2025
Figure 46. APAC GefitinibTablets Revenue Market Share by Region (2020-2025)
Figure 47. APAC GefitinibTablets Sales Market Share by Type (2020-2025)
Figure 48. APAC GefitinibTablets Sales Market Share by Application (2020-2025)
Figure 49. China GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 53. India GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe GefitinibTablets Sales Market Share by Country in 2025
Figure 57. Europe GefitinibTablets Revenue Market Share by Country (2020-2025)
Figure 58. Europe GefitinibTablets Sales Market Share by Type (2020-2025)
Figure 59. Europe GefitinibTablets Sales Market Share by Application (2020-2025)
Figure 60. Germany GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 61. France GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 62. UK GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa GefitinibTablets Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa GefitinibTablets Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa GefitinibTablets Sales Market Share by Application (2020-2025)
Figure 68. Egypt GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of GefitinibTablets in 2025
Figure 74. Manufacturing Process Analysis of GefitinibTablets
Figure 75. Industry Chain Structure of GefitinibTablets
Figure 76. Channels of Distribution
Figure 77. Global GefitinibTablets Sales Market Forecast by Region (2026-2031)
Figure 78. Global GefitinibTablets Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global GefitinibTablets Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global GefitinibTablets Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global GefitinibTablets Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global GefitinibTablets Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of GefitinibTablets
Figure 2. GefitinibTablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global GefitinibTablets Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global GefitinibTablets Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. GefitinibTablets Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. GefitinibTablets Sales Market Share by Country/Region (2024)
Figure 10. GefitinibTablets Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Original Drugs
Figure 12. Product Picture of Generic Drugs
Figure 13. Global GefitinibTablets Sales Market Share by Type in 2025
Figure 14. Global GefitinibTablets Revenue Market Share by Type (2020-2025)
Figure 15. GefitinibTablets Consumed in Breast Cancer
Figure 16. Global GefitinibTablets Market: Breast Cancer (2020-2025) & (K Units)
Figure 17. GefitinibTablets Consumed in Lung Cancer
Figure 18. Global GefitinibTablets Market: Lung Cancer (2020-2025) & (K Units)
Figure 19. GefitinibTablets Consumed in Other
Figure 20. Global GefitinibTablets Market: Other (2020-2025) & (K Units)
Figure 21. Global GefitinibTablets Sale Market Share by Application (2024)
Figure 22. Global GefitinibTablets Revenue Market Share by Application in 2025
Figure 23. GefitinibTablets Sales by Company in 2025 (K Units)
Figure 24. Global GefitinibTablets Sales Market Share by Company in 2025
Figure 25. GefitinibTablets Revenue by Company in 2025 ($ millions)
Figure 26. Global GefitinibTablets Revenue Market Share by Company in 2025
Figure 27. Global GefitinibTablets Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global GefitinibTablets Revenue Market Share by Geographic Region in 2025
Figure 29. Americas GefitinibTablets Sales 2020-2025 (K Units)
Figure 30. Americas GefitinibTablets Revenue 2020-2025 ($ millions)
Figure 31. APAC GefitinibTablets Sales 2020-2025 (K Units)
Figure 32. APAC GefitinibTablets Revenue 2020-2025 ($ millions)
Figure 33. Europe GefitinibTablets Sales 2020-2025 (K Units)
Figure 34. Europe GefitinibTablets Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa GefitinibTablets Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa GefitinibTablets Revenue 2020-2025 ($ millions)
Figure 37. Americas GefitinibTablets Sales Market Share by Country in 2025
Figure 38. Americas GefitinibTablets Revenue Market Share by Country (2020-2025)
Figure 39. Americas GefitinibTablets Sales Market Share by Type (2020-2025)
Figure 40. Americas GefitinibTablets Sales Market Share by Application (2020-2025)
Figure 41. United States GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC GefitinibTablets Sales Market Share by Region in 2025
Figure 46. APAC GefitinibTablets Revenue Market Share by Region (2020-2025)
Figure 47. APAC GefitinibTablets Sales Market Share by Type (2020-2025)
Figure 48. APAC GefitinibTablets Sales Market Share by Application (2020-2025)
Figure 49. China GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 53. India GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe GefitinibTablets Sales Market Share by Country in 2025
Figure 57. Europe GefitinibTablets Revenue Market Share by Country (2020-2025)
Figure 58. Europe GefitinibTablets Sales Market Share by Type (2020-2025)
Figure 59. Europe GefitinibTablets Sales Market Share by Application (2020-2025)
Figure 60. Germany GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 61. France GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 62. UK GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa GefitinibTablets Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa GefitinibTablets Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa GefitinibTablets Sales Market Share by Application (2020-2025)
Figure 68. Egypt GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries GefitinibTablets Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of GefitinibTablets in 2025
Figure 74. Manufacturing Process Analysis of GefitinibTablets
Figure 75. Industry Chain Structure of GefitinibTablets
Figure 76. Channels of Distribution
Figure 77. Global GefitinibTablets Sales Market Forecast by Region (2026-2031)
Figure 78. Global GefitinibTablets Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global GefitinibTablets Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global GefitinibTablets Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global GefitinibTablets Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global GefitinibTablets Revenue Market Share Forecast by Application (2026-2031)
